| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Provention Bio, Inc. | Director | Common Stock | 10,000 | $243,200 | $24.32 | 13 Apr 2023 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 4,350 | $130,500 | $30.00 | 30 May 2024 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Stock Option (right to buy) | 2,783 | $13,832 | $4.97 | 16 May 2024 | Direct |
| Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | 27 Apr 2023 | By the Avery Catlin Charitable Giving Fund | |
| Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | 27 Apr 2023 | By the Avery W. Catlin Revocable Trust | |
| Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | 27 Apr 2023 | Direct |